LRRK2 and Parkinson disease: PD patient-derived fibroblast lines harboring a LRRK2 mutation (G2019S) had significantly more Parkin rings (p < 0.05), compared to healthy subject controls and the other PD patient-derived fibroblast lines (Fig. 4e).